| Status | Study |
| Active, not recruiting |
Study Name: A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions Condition: Hereditary Angioedema Date: 2017-04-24 Interventions: Drug: BCX7353 Day 11-18 for Co |
| Recruiting |
Study Name: Biomarker for Hereditary Angioedema Disease Type 1 Condition: Hereditary AngioEdema Angioedema, Date: 2017-01-18 |
| Not yet recruiting |
Study Name: Treatment of Idiopathic Angioedema With Xolair as Add-on Therapy Condition: Idiopathic Angioedema Date: 2016-11-15 Interventions: Drug: Omalizumab Omalizumab 30 |
| Recruiting |
Study Name: The Role of the Coagulation Pathways in Recurrent Angioedema Condition: Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency Date: 2016-09-02 Interventions: Other: BLOOD TEST |
| Recruiting |
Study Name: Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema Condition: Hereditary Angioedema (HAE) Date: 2016-08-10 Interventions: Drug: BCX7353 Plasma kallikrei |
| Active, not recruiting |
Study Name: Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) Condition: Hereditary Angioedema (HAE) Date: 2016-08-09 Interventions: Drug: CINRYZE 500 U IV infusio |
| Recruiting |
Study Name: Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population Condition: Hereditary Angioedema Healthy Volunteers Date: 2016-07-18 Interventions: Other: blood sample |
| Completed |
Study Name: Analysis of the Availability of the Treatments for ACE-I and ARB-induced Angioedema Condition: ACE-I and ARB-induced Angioedema. Date: 2016-07-05 |
| Recruiting |
Study Name: Determination of Specific Biomarkers of Angioneurotic Crisis Condition: Angioedema Date: 2016-06-28 |
| Completed |
Study Name: An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates Condition: Hereditary Angioedema Date: 2016-06-28 Interventions: Drug: BCX7353 and probes |